Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on PEG-rhG-CSF in Belgium
Total 0 results
Nothing found
Sponsors and Collaborators
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Hospital ASEPEYO Sant Cugat
Kupfer, David J., M.D.
Agency for Science, Technology and Research
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Mª Victoria Maestre Sanchez
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
iCAD
Apollo Neuroscience, Inc.
Nacuity Pharmaceuticals, Inc.
Neurophth Therapeutics Inc
GFI
Korean Society of Spine Surgery
Aptis Medical
Alma Lasers Inc.
Everett Meyer
ASST Cremona, Cremona
Hospital Durand, Argentina
Eurofins Genoma
RMIT University, Melbourne, Australia
View Full List
Medical Conditions
Metachronous Adenoma
Gastric Cancer Stage IIIB-IIIC
Major Liver Surgery
Disorder of Fluid Balance
Chronic Constipation Symptoms
Treatment Decisions
The Strength Properties of the Aorta in Vitro
Dienogest
Splenic Trauma
Immune-Mediated Inflammatory Disease
Fever
RISS Stage III Plasma Cell Myeloma
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Scleredema
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Rheumatoid Arthritis(RA)
Recurrent Clear Cell Sarcoma of Soft Tissue
Luteal Phase Support
T-LGL Leukemia
Corneal Cross-Linking
View Full List
Drug Interventions
Desvenlafaxine
Midazolam
Intravenous deferiprone
Capecitabine and IMRT (if randomized to this arm)
MLN2480
Anticholinergic
TPN-101
GLPG1837 multiple ascending doses
PD-1/PD-L1 inhibitor
Oxycodone/acetaminophen 5/325 mg
Fospropofol disodium, propofol
Intravenous Formulation of PD-0332991
Camptosar
OnabotulinumtoxinA
Standard of care (SOC) for COVID-19
Letrozole
RDX227675
THC
Olopatadine
Capecitabine/cisplatin
View Full List
CROs by country
Contract Research Organizations in Czech Republic
Contract Research Organizations in Ethiopia
Contract Research Organizations in Ghana
Contract Research Organizations in Greece
Contract Research Organizations in Latvia
Contract Research Organizations in Lebanon
Contract Research Organizations in Malaysia
Contract Research Organizations in Philippines
Contract Research Organizations in Serbia
Contract Research Organizations in Singapore
Contract Research Organizations in Slovakia
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Congo
SGS
All CROs in Congo
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe